Market capitalization is just a fancy declare for a comprehensible concept: it is the market value of a company's outstanding shares. The company's market cap is $110.64 Billion, and the average volume is $6.26 Million. The stock decreased 0.34% or $0.37 during the last trading session, reaching $108.93. About 5.39M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since March 6, 2017 and is downtrending. It has outperformed by 27.69% the S&P500.
Integre Asset Management Llc decreased its stake in Bristol (BMY) by 19.03% based on its latest 2017Q3 regulatory filing with the SEC. Bristol-Myers Squibb Company was covered by a number of analysts recently, 6 rated the stock as Buy, 4 rated Outperform, 11 rated Hold, 2 gave an Underperform and 1 rated sell.
Returns and Valuations for The Williams Companies, Inc. The company has market cap of $4.65 billion. This is the price at which the trader or investor wants to exit his existing position so he can realize the most reward. Zeke Cap Ltd Company holds 0.27% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 30,969 shares. It has underperformed by 16.70% the S&P500. Pnc Fincl Services Grp Inc Inc reported 0.4% stake.
Since September 6, 2017, it had 1 buying transaction, and 1 sale for $85,985 activity. (NASDAQ:PTLA) on Tuesday, May 31 to "Neutral" rating. (NASDAQ:ADSK) for 596,160 shares.
Traders have different rules for what constitutes liquidity and a good guide is the volume of trades and volume of shares that are traded each day. $3.29M worth of stock was sold by FISCHER DAVID B. on Tuesday, February 27. Blum Steven M sold $1.02 million worth of stock. It closed at $2.27 lastly.
When we look at the Analyst Recommendations of the stock, the company has 2.1 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell. Therefore 81% are positive. Avago Technologies Limited had 174 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned "Hold" rating by DZ Bank on Wednesday, February 28. RBC Capital Markets maintained Main Street Capital Corporation (NYSE:MAIN) on Sunday, November 5 with "Buy" rating. The firm has "Hold" rating given on Thursday, November 16 by Jefferies. The firm has "Outperform" rating by Robert W. Baird given on Wednesday, April 26. Piper Jaffray maintained Facebook, Inc. The firm has "Buy" rating given on Tuesday, February 6 by Leerink Swann. Sterneck Capital Mngmt Ltd Llc stated it has 0.3% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). The stock of Dycom Industries, Inc. The rating was upgraded by Goldman Sachs to "Conviction Buy" on Wednesday, April 5. UBS maintained the shares of BMY in report on Friday, October 6 with "Buy" rating. The rating was downgraded by BMO Capital Markets on Monday, January 25 to "Market Perform". As per Tuesday, September 12, the company rating was downgraded by Hilliard Lyons. Bank of America maintained it with "Neutral" rating and $68 target in Monday, March 5 report.
Liverpool Reportedly Closing in on Thomas Lemar Acquisition
Le10Sport claim Lemar is close to agreeing financial terms with the Reds over a move , with talks having taken place recently. Griezmann was last week linked to a Barcelona with Spanish sources alleging that a verbal deal has already been agreed.
Investors sentiment decreased to 0.83 in 2017 Q3. Its up 0.08, from 0.95 in 2017Q2. First Quadrant Lp Ca reported 4,700 shares. Colonial Tru accumulated 7,729 shares. Fulton Bank & Trust Na holds 21,585 shares or 0.1% of its portfolio. Burney invested in 0.04% or 15,294 shares. 88,398 are owned by California State Teachers Retirement Systems. Lesa Sroufe And reported 0.41% of its portfolio in Facebook, Inc. (NASDAQ:PTLA). Valley Natl Advisers holds 0.02% or 1,250 shares in its portfolio. Stonebridge Capital Advsr Limited Liability Co accumulated 79,364 shares. The Washington-based Parametric Portfolio Assoc Llc has invested 0% in Portola Pharmaceuticals, Inc. (NASDAQ:FB). Baskin Ser Inc has 2.1% invested in Facebook, Inc. (NASDAQ:ADSK) for 8,265 shares. Atria Invs Ltd holds 6,098 shares. The Nasdaq composite advanced 1 percent to close at 7,330.70. Thompson Siegel Walmsley Ltd Com holds 100 shares. (NASDAQ:FB) or 1,209 shares. The stock declared an annual dividend of $2.39% per share. Wellington Shields Limited Com reported 46,504 shares. This represents a $1.60 annualized dividend and a yield of 2.44%. Its up 0.08, from 0.95 in 2017Q2. It increased, as 62 investors sold BMY shares while 519 reduced holdings. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. Northern Trust accumulated 0.01% or 538,676 shares. 21,336 are held by Paloma Partners Management.
Bristol-Myers Squibb Company has distance from 20-day Simple Moving Average (SMA20) of 1.6%, Distance from 50-Day Simple Moving Average of SMA50 percent and Distance from 200-Day Simple Moving Average of 9.97%.
Analyst's mean target price for AR is $25.75 while analysts mean suggestion is 2.3. According to today's trading volume Bristol-Myers Squibb Company is BELOW its 20-Day Avg. volume with the stock showing BELOW Abnormal volume in the past 150 days. Whitnell &, a Illinois-based fund reported 23,362 shares. Altfest L J & Commerce owns 57,563 shares or 1.78% of their USA portfolio. Massachusetts-based Northeast Management has invested 1.54% in Bristol-Myers Squibb Company (NYSE:BMY). (NYSE:AZO). Fiera Corporation holds 1.31% or 460,382 shares in its portfolio. Principal reported 0.16% stake.
Relative strength index (RSI-14) for Bristol-Myers Squibb Company (BMY) is at 56.73. Folger Nolan Fleming Douglas Cap Mgmt Inc reported 17,223 shares or 0.16% of all its holdings.
Bristol-Myers Squibb Company (NYSE:BMY) reported its EPS in the last quarter as $0.68/Share beating the analyst estimate of $0.67/Share by a difference of $0.01. They expect $0.87 EPS, up 3.57% or $0.03 from last year's $0.84 per share. BMY's profit will be $1.42 billion for 19.01 P/E if the $0.87 EPS becomes a reality.
EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS of Bristol-Myers Squibb Company (NYSE:BMY) stands at -10.90%, and looking further price to next year's EPS is 17.26%.